![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Cannabis Use Disorder
Adolescents and adults increasingly view cannabis as harmless. While the majority can use cannabis without harm, there are many potential problems including decline in educational or occupational functioning a...
-
Chapter
Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence
Opioid overdose (illicit, prescription, nonmedical prescription) is the leading cause of accidental death in the United States. Alternative analgesics are warranted among chronic pain patients given the associ...
-
Chapter
Cannabinoids and Adolescence
Adolescence is a period for cortical maturation and neuronal development, particularly among frontal areas pertaining to executive function, decision-making, and reasoning. For these reasons, the adolescent br...
-
Chapter
Cannabinoid-Related Adverse Events and Impairment
In addition to therapeutic benefits, cannabis also causes cognitive and psychomotor impairment in some individuals. Common acute adverse events can be cannabinoid-specific, such as those related to THC (e.g., ...
-
Chapter
Cannabinoids and Mental Health Risks
Recreational cannabis use has been associated with the development of psychosis; as such, there are numerous biopsychosocial risks and vulnerabilities to consider. The Diagnostic and Statistical Manual 5th Editio...
-
Chapter
Cannabinoid-Based Medicines: Dosing, Titration & Monitoring
Variations in cannabis formulations and methods of administration influence dosing, titration, and monitoring methodology. Smoking/vaporization, oral, oromucosal, and topical routes of administration each have...